Lamtidine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171947This classification denotes a histamine-2 receptor antagonist with the molecular formula C18H28N6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BO55Z3JL5K, chemically known as 1-(m-(3-((3-amino-1-methyl-1h-1,2,4-triazol-5-yl)amino)propoxy)benzyl)piperidine but generally known as lamtidine, which bears US NIH Compound Identifier 71988. European Medicines Agency schedules Lamtidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08394MIG. The term LAMTIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). LAMTIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lamtidine under HS 29333999 and SITC 51574. As of Q4 2014, LAMTIDINE remains the US FDA Preferred Term for this commodity. Lamtidine bears US NLM identifiers UMLS ID C0064637 and NCI Concept Code C79118. SMILES: O(C1CC(CN2CCCCC2)CCC1)CCCNC1N(NC(N1)N)C.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.